Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 1
2005 2
2006 6
2007 2
2008 2
2009 2
2010 2
2011 1
2012 5
2013 7
2014 6
2015 5
2016 3
2017 2
2018 9
2019 10
2020 17
2021 13
2022 5
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
RAVER1 hinders lethal EMT and modulates miR/RISC activity by the control of alternative splicing.
Wedler A, Bley N, Glaß M, Müller S, Rausch A, Lederer M, Urbainski J, Schian L, Obika KB, Simon T, Peters LM, Misiak C, Fuchs T, Köhn M, Jacob R, Gutschner T, Ihling C, Sinz A, Hüttelmaier S. Wedler A, et al. Among authors: huttelmaier s. Nucleic Acids Res. 2024 Apr 24;52(7):3971-3988. doi: 10.1093/nar/gkae046. Nucleic Acids Res. 2024. PMID: 38300787 Free PMC article.
RNA-binding proteins in cancer drug discovery.
Bertoldo JB, Müller S, Hüttelmaier S. Bertoldo JB, et al. Among authors: huttelmaier s. Drug Discov Today. 2023 Jun;28(6):103580. doi: 10.1016/j.drudis.2023.103580. Epub 2023 Apr 7. Drug Discov Today. 2023. PMID: 37031812 Review.
Correction: Identification of lymphocyte cell-specific protein-tyrosine kinase (LCK) as a driver for invasion and migration of oral cancer by tumor heterogeneity exploitation.
Weiße J, Rosemann J, Müller L, Kappler M, Eckert AW, Glaß M, Misiak D, Hüttelmaier S, Ballhausen WG, Hatzfeld M, Haemmerle M, Gutschner T. Weiße J, et al. Among authors: huttelmaier s. Mol Cancer. 2023 Mar 14;22(1):50. doi: 10.1186/s12943-023-01758-2. Mol Cancer. 2023. PMID: 36918841 Free PMC article. No abstract available.
RUNX1 isoform disequilibrium promotes the development of trisomy 21-associated myeloid leukemia.
Gialesaki S, Bräuer-Hartmann D, Issa H, Bhayadia R, Alejo-Valle O, Verboon L, Schmell AL, Laszig S, Regényi E, Schuschel K, Labuhn M, Ng M, Winkler R, Ihling C, Sinz A, Glaß M, Hüttelmaier S, Matzk S, Schmid L, Strüwe FJ, Kadel SK, Reinhardt D, Yaspo ML, Heckl D, Klusmann JH. Gialesaki S, et al. Among authors: huttelmaier s. Blood. 2023 Mar 9;141(10):1105-1118. doi: 10.1182/blood.2022017619. Blood. 2023. PMID: 36493345 Free PMC article.
The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL.
Stachelscheid J, Jiang Q, Aszyk C, Warner K, Bley N, Müller T, Vydzhak O, Symeonidis K, Crispatzu G, Mayer P, Blakemore SJ, Goehring G, Newrzela S, Hippler S, Robrecht S, Kreuzer KA, Pallasch C, Krüger M, Lechner A, Fischer K, Stilgenbauer S, Beutner D, Hallek M, Auguin D, Hüttelmaier S, Bloehdorn J, Vasyutina E, Herling M. Stachelscheid J, et al. Among authors: huttelmaier s. Blood. 2023 Mar 23;141(12):1425-1441. doi: 10.1182/blood.2022015494. Blood. 2023. PMID: 36179280 Free article.
108 results